- CMPS Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
COMPASS Pathways (CMPS) Financial statements
Company Profile
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|
Total Revenue | ||||||
Cost of Revenue | ||||||
Gross Profit | ||||||
Gross Profit Margin (%) | ||||||
R&D Expense | ||||||
SG&A Expense | ||||||
Total Operating Expenses | ||||||
Operating Income or Loss | ||||||
Operating Margin (%) | ||||||
Interest Expense | ||||||
Total Other Income/Expenses | ||||||
Income Before Tax | ||||||
Income Tax Expense | ||||||
Income from Continuing Ops. | ||||||
Net Income | ||||||
Net Profit Margin (%) | ||||||
Net Income Available to Common Shareholders | ||||||
Basic EPS | ||||||
Diluted EPS | ||||||
Basic Average Shares | ||||||
Diluted Average Shares |
Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||
Cost of Revenue | |||||||||||||||
Gross Profit | |||||||||||||||
Gross Profit Margin (%) | |||||||||||||||
R&D Expense | |||||||||||||||
SG&A Expense | |||||||||||||||
Total Operating Expenses | |||||||||||||||
Operating Income or Loss | |||||||||||||||
Operating Margin (%) | |||||||||||||||
Interest Expense | |||||||||||||||
Total Other Income/Expenses | |||||||||||||||
Income Before Tax | |||||||||||||||
Income Tax Expense | |||||||||||||||
Income from Continuing Ops. | |||||||||||||||
Net Income | |||||||||||||||
Net Profit Margin (%) | |||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||
Basic EPS | |||||||||||||||
Diluted EPS | |||||||||||||||
Basic Average Shares | |||||||||||||||
Diluted Average Shares |
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|
Current Assets | ||||||
Cash & Cash Equivalents | ||||||
Marketable Securities | ||||||
Receivables | ||||||
Inventories | ||||||
Other Current Assets | ||||||
Total Current Assets | ||||||
Non-Current Assets | ||||||
Marketable Securities | ||||||
PPE Net | ||||||
Intangibles inc. Goodwill | ||||||
Other Non-Current Assets | ||||||
Total Non-Current Assets | ||||||
Total Assets | ||||||
Current Liabilities | ||||||
Accounts Payable | ||||||
Deferred Revenues | ||||||
Debt, Current | ||||||
Accrued Liabilities | ||||||
Other Current Liabilities | ||||||
Total Current Liabilities | ||||||
Non-Current Liabilities | ||||||
Deferred Revenues | ||||||
Debt, Non-Current | ||||||
Other Non-Current Liabilities | ||||||
Total Non-Current Liabilities | ||||||
Total Liabilities | ||||||
Shareholders' Equity | ||||||
Common Stock | ||||||
Additional Paid-In Capital | ||||||
Retained Earnings | ||||||
Other Shareholders' Equity | ||||||
Total Shareholders' Equity | ||||||
Total Liabilities & Shareholders' Equity |
Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||
Cash & Cash Equivalents | |||||||||||||||
Marketable Securities | |||||||||||||||
Receivables | |||||||||||||||
Inventories | |||||||||||||||
Other Current Assets | |||||||||||||||
Total Current Assets | |||||||||||||||
Non-Current Assets | |||||||||||||||
Marketable Securities | |||||||||||||||
PPE Net | |||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||
Other Non-Current Assets | |||||||||||||||
Total Non-Current Assets | |||||||||||||||
Total Assets | |||||||||||||||
Current Liabilities | |||||||||||||||
Accounts Payable | |||||||||||||||
Deferred Revenues | |||||||||||||||
Debt, Current | |||||||||||||||
Accrued Liabilities | |||||||||||||||
Other Current Liabilities | |||||||||||||||
Total Current Liabilities | |||||||||||||||
Non-Current Liabilities | |||||||||||||||
Deferred Revenues | |||||||||||||||
Debt, Non-Current | |||||||||||||||
Other Non-Current Liabilities | |||||||||||||||
Total Non-Current Liabilities | |||||||||||||||
Total Liabilities | |||||||||||||||
Shareholders' Equity | |||||||||||||||
Common Stock | |||||||||||||||
Additional Paid-In Capital | |||||||||||||||
Retained Earnings | |||||||||||||||
Other Shareholders' Equity | |||||||||||||||
Total Shareholders' Equity | |||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||
Net Income | ||||||
Depreciation & Amortization | ||||||
Deferred Income Taxes | ||||||
Stock Based Compensation | ||||||
Accounts Receivable | ||||||
Inventory | ||||||
Accounts Payable | ||||||
Deferred Revenue | ||||||
Other Non-Cash | ||||||
Operating Cash Flow | ||||||
Cash Flows from Investing Activities | ||||||
PPE Investments | ||||||
Net Acquisitions | ||||||
Purchase of Investments | ||||||
Sale of Investments | ||||||
Other Investing Activity | ||||||
Investing Cash Flow | ||||||
Cash Flows from Financing Activities | ||||||
Debt Issued | ||||||
Proceeds from Debt Repayment | ||||||
Debt Repayment | ||||||
Proceeds from Sale of Equity | ||||||
Equity Repurchased | ||||||
Dividend Paid | ||||||
Other Financing Activity | ||||||
Financing Cash Flow | ||||||
Cash Position | ||||||
Beginning Cash Position | ||||||
End Cash Position | ||||||
Change in Cash | ||||||
Free Cash Flow | ||||||
Operating Cash Flow | ||||||
Capital Expenditure | ||||||
Free Cash Flow |
Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||
Net Income | |||||||||||||||
Depreciation & Amortization | |||||||||||||||
Deferred Income Taxes | |||||||||||||||
Stock Based Compensation | |||||||||||||||
Accounts Receivable | |||||||||||||||
Inventory | |||||||||||||||
Accounts Payable | |||||||||||||||
Deferred Revenue | |||||||||||||||
Other Non-Cash | |||||||||||||||
Operating Cash Flow | |||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||
PPE Investments | |||||||||||||||
Net Acquisitions | |||||||||||||||
Purchase of Investments | |||||||||||||||
Sale of Investments | |||||||||||||||
Other Investing Activity | |||||||||||||||
Investing Cash Flow | |||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||
Debt Issued | |||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||
Debt Repayment | |||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||
Equity Repurchased | |||||||||||||||
Dividend Paid | |||||||||||||||
Other Financing Activity | |||||||||||||||
Financing Cash Flow | |||||||||||||||
Cash Position | |||||||||||||||
Beginning Cash Position | |||||||||||||||
End Cash Position | |||||||||||||||
Change in Cash | |||||||||||||||
Free Cash Flow | |||||||||||||||
Operating Cash Flow | |||||||||||||||
Capital Expenditure | |||||||||||||||
Free Cash Flow |